References
- Flenady V, Koopmans L, Middleton P, et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet 2011;377:1331-40
- Bhutta ZA, Yakoob MY, Lawn JE, et al. Stillbirths: what difference can we make and at what cost? Lancet 2011;377:1523-38
- Poon LL, Leung TN, Lau TK, Lo YM. Presence of fetal RNA in maternal plasma. Clin Chem 2000;46:1832-4
- Lawn JE, Blencowe H, Pattinson R, et al. Stillbirths: where? When? Why? How to make the data count? Lancet 2011;377:1448-63
- Lawn JE, Lee AC, Kinney M, et al. Two million intrapartum-related stillbirths and neonatal deaths: where, why, and what can be done? Int J Gynaecol Obstet 2009;107(Suppl 1):S5-18. S19
- Ross MG. Labor and fetal heart rate decelerations: relation to fetal metabolic acidosis. Clin Obstet Gynecol 2011;54:74-82
- Baschat AA. Fetal growth restriction – from observation to intervention. J Perinatal Med 2010;38:239-46
- Whitehead C, Teh WT, Walker SP, et al. Quantifying circulating hypoxia-induced RNA transcripts in maternal blood to determine in utero fetal hypoxic status. BMC Med 2013;11:256
- Whitehead CL, Teh WT, Walker SP, et al. Circulating MicroRNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero. PLoS One 2013;8:e78487